Dan Liang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dan Liang has a total of 187 co-authors. Here are the top co-authors by number of shared publications:
Xiaoqing Chen
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, WHO Collaborating Centre for Eye Care and Vision, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Sun Yat-Sen University, Guangzhou, Guangdong, China
27 shared publicationsZhuang Li
20 shared publications- Wenru Su
Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200001, China
17 shared publications Yanyan Xie
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, WHO Collaborating Centre for Eye Care and Vision, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Sun Yat-Sen University, Guangzhou, Guangdong, China
17 shared publicationsGuanyu Chen
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, WHO Collaborating Centre for Eye Care and Vision, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Sun Yat-Sen University, Guangzhou, Guangdong, China
16 shared publicationsYunwei Hu
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China; Ophthalmic Center, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330000, China
14 shared publications
Latest Publications
- 28 August 2026
- Published by BMJ in British Journal of Ophthalmology
Novel insights of minocycline as a neurovascular protective agent in retinitis pigmentosa
Background/aims: Retinitis pigmentosa (RP) is characterised by progressive photoreceptor degeneration accompanied by vascular abnormalities. We have previously demonstrated that minocycline exhibits therapeutic potential in RP. This trial aimed to evaluate its neurovascular protective effects. Methods: Patients with RP were enrolled and administered 100 mg of minocycline once daily for 12 months. A total of 32 eyes from 16 participants were included. The primary outcomes were changes in retinal and choroidal vasculature, including vessel density, lacunarity, foveal avascular zone (FAZ) area, fluorescein angiography (FA) score and subfoveal choroidal thickness (SFCT). The secondary outcomes included changes in photoreceptor structure and function, including ellipsoid zone width, best-corrected visual acuity (BCVA), mean macular sensitivity, mean deviation (MD) and error score. Adverse events were recorded. Additionally, Rd1 mice were used to further investigate the vascular effects of minocycline. Results: After 12-month minocycline treatment, RP patients exhibited increased vessel density in both the retinal superficial capillary plexus (SCP) and retinal deep capillary plexus (DCP), accompanied by reduced FAZ area and decreased lacunarity in the SCP and DCP. FA score and SFCT remained stable, as did all secondary outcomes. A total of 24 adverse events were reported in 8 patients, and all resolved spontaneously without additional intervention. Additional experiments in Rd1 mice demonstrated improved retinal vascular abnormalities and preserved blood–retinal barrier integrity, accompanied by upregulated expression of tight junction proteins. Conclusions: Oral 100 mg minocycline once daily for 12 months was beneficial to protect vascular integrity and stabilise photoreceptor structure and function with good tolerability.
- 28 August 2026
- Published by BMJ in British Journal of Ophthalmology
Novel insights of minocycline as a neurovascular protective agent in retinitis pigmentosa
Background/aims: Retinitis pigmentosa (RP) is characterised by progressive photoreceptor degeneration accompanied by vascular abnormalities. We have previously demonstrated that minocycline exhibits therapeutic potential in RP. This trial aimed to evaluate its neurovascular protective effects. Methods: Patients with RP were enrolled and administered 100 mg of minocycline once daily for 12 months. A total of 32 eyes from 16 participants were included. The primary outcomes were changes in retinal and choroidal vasculature, including vessel density, lacunarity, foveal avascular zone (FAZ) area, fluorescein angiography (FA) score and subfoveal choroidal thickness (SFCT). The secondary outcomes included changes in photoreceptor structure and function, including ellipsoid zone width, best-corrected visual acuity (BCVA), mean macular sensitivity, mean deviation (MD) and error score. Adverse events were recorded. Additionally, Rd1 mice were used to further investigate the vascular effects of minocycline. Results: After 12-month minocycline treatment, RP patients exhibited increased vessel density in both the retinal superficial capillary plexus (SCP) and retinal deep capillary plexus (DCP), accompanied by reduced FAZ area and decreased lacunarity in the SCP and DCP. FA score and SFCT remained stable, as did all secondary outcomes. A total of 24 adverse events were reported in 8 patients, and all resolved spontaneously without additional intervention. Additional experiments in Rd1 mice demonstrated improved retinal vascular abnormalities and preserved blood–retinal barrier integrity, accompanied by upregulated expression of tight junction proteins. Conclusions: Oral 100 mg minocycline once daily for 12 months was beneficial to protect vascular integrity and stabilise photoreceptor structure and function with good tolerability.
- Open Access
- 16 July 2026
- Published by S. Karger AG in Case Reports in Ophthalmology
- p. 1-7
An Occult Intraocular Eyelash Masquerading as Chronic Recurrent Uveitis: A Case Report
Introduction: Intraocular foreign bodies (IOFBs) can induce recurrent uveitis and may be easily overlooked when a plausible systemic etiology, such as HLA-B27 positivity, is present. This report documents a diagnostic challenge where an occult eyelash masqueraded as HLA-B27-associated disease. Case Presentation: A 13-year-old female with HLA-B27 positivity presented with four episodes of recurrent unilateral anterior uveitis, initially diagnosed and treated as HLA-B27-associated uveitis. Following the resolution of active inflammation with medical therapy, a subtle iris protuberance was identified at the 5 o’clock position. Ultrasound biomicroscopy confirmed a hyper-reflective foreign body embedded in the angle recess. Following successful surgical removal of an eyelash, the inflammation resolved rapidly with no recurrence over a 2-year follow-up period. Conclusion: This case underscores that occult IOFBs should be considered in the differential diagnosis of recalcitrant unilateral uveitis, even when systemic associations are present. Careful re-examination after inflammation subsides and the appropriate use of imaging modalities like UBM are essential to prevent diagnostic delays and preserve vision.
- 16 July 2026
- Published by S. Karger AG in Case Reports in Ophthalmology
- p. 1-7
Open AccessAn Occult Intraocular Eyelash Masquerading as Chronic Recurrent Uveitis: A Case Report
Introduction: Intraocular foreign bodies (IOFBs) can induce recurrent uveitis and may be easily overlooked when a plausible systemic etiology, such as HLA-B27 positivity, is present. This report documents a diagnostic challenge where an occult eyelash masqueraded as HLA-B27-associated disease. Case Presentation: A 13-year-old female with HLA-B27 positivity presented with four episodes of recurrent unilateral anterior uveitis, initially diagnosed and treated as HLA-B27-associated uveitis. Following the resolution of active inflammation with medical therapy, a subtle iris protuberance was identified at the 5 o’clock position. Ultrasound biomicroscopy confirmed a hyper-reflective foreign body embedded in the angle recess. Following successful surgical removal of an eyelash, the inflammation resolved rapidly with no recurrence over a 2-year follow-up period. Conclusion: This case underscores that occult IOFBs should be considered in the differential diagnosis of recalcitrant unilateral uveitis, even when systemic associations are present. Careful re-examination after inflammation subsides and the appropriate use of imaging modalities like UBM are essential to prevent diagnostic delays and preserve vision.
- Open Access
- 10 July 2026
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 23 (1) , 269
Phosphorylated TYK2 orchestrates the pathogenic program of CD4 + T cells in the development of CNS autoimmunity
The imbalance between pathogenic Th1/Th17 cells and regulatory T cells (Tregs) is a central mechanism in central nervous system (CNS) autoimmune diseases,
- 10 July 2026
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 23 (1) , 269
Open AccessPhosphorylated TYK2 orchestrates the pathogenic program of CD4 + T cells in the development of CNS autoimmunity
The imbalance between pathogenic Th1/Th17 cells and regulatory T cells (Tregs) is a central mechanism in central nervous system (CNS) autoimmune diseases,
- Open Access
- 17 March 2026
- Published by Elsevier in SSRN Electronic Journal
Phosphorylated TYK2 Orchestrates the Pathogenic Program of CD4+ T Cells in the Development of CNS Autoimmunity
Background: Tyrosine kinase 2 (TYK2) is a validated therapeutic target in psoriasis, but its role in central nervous system (CNS) autoimmunity driven by CD4+ T cells remains unclear. We aimed to investigate the subset-specific activation of TYK2 and the therapeutic potential of selective TYK2 inhibition in CNS autoimmune diseases.Methods: We examined TYK2 phosphorylation in CD4+ T cell subsets from autoimmune uveitis patients and from experimental autoimmune uveitis (EAU) and encephalomyelitis (EAE) models. Therapeutic efficacy and mechanism of the selective TYK2 inhibitor were assessed by flow cytometry, single-cell RNA sequencing, adoptive transfer, in vitro cellular assays, and ex vivo patient sample stimulation.Findings: TYK2 phosphorylation was preferentially activated in Th1 and Th17 cells compared with regulatory T cells (Tregs) in patients and both disease models. TYK2 inhibition significantly reduced clinical and histopathological scores in EAU and EAE, suppressing Th1/Th17 differentiation and production of IFN-γ and IL-17A, while Treg proportions and function remained intact. Mechanistically, we found that IFN-α/β, IL-12, and IL-23—but not IL-2—induced TYK2 phosphorylation in CD4+ T cells. Accordingly, TYK2 blockade selectively inhibited STAT1/2/3/4 activation downstream of these cytokines, but did not affect IL-2-induced STAT5 phosphorylation in Tregs. These lineage-selective effects were confirmed in peripheral blood mononuclear cells from autoimmune uveitis patients.Interpretation: Selective TYK2 inhibition suppresses pathogenic Th1/Th17 responses while preserving the proportion and function of Tregs, offering a precision therapeutic strategy for CNS autoimmunity by rebalancing the effector–regulatory immune axis.
- 17 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessPhosphorylated TYK2 Orchestrates the Pathogenic Program of CD4+ T Cells in the Development of CNS Autoimmunity
Background: Tyrosine kinase 2 (TYK2) is a validated therapeutic target in psoriasis, but its role in central nervous system (CNS) autoimmunity driven by CD4+ T cells remains unclear. We aimed to investigate the subset-specific activation of TYK2 and the therapeutic potential of selective TYK2 inhibition in CNS autoimmune diseases.Methods: We examined TYK2 phosphorylation in CD4+ T cell subsets from autoimmune uveitis patients and from experimental autoimmune uveitis (EAU) and encephalomyelitis (EAE) models. Therapeutic efficacy and mechanism of the selective TYK2 inhibitor were assessed by flow cytometry, single-cell RNA sequencing, adoptive transfer, in vitro cellular assays, and ex vivo patient sample stimulation.Findings: TYK2 phosphorylation was preferentially activated in Th1 and Th17 cells compared with regulatory T cells (Tregs) in patients and both disease models. TYK2 inhibition significantly reduced clinical and histopathological scores in EAU and EAE, suppressing Th1/Th17 differentiation and production of IFN-γ and IL-17A, while Treg proportions and function remained intact. Mechanistically, we found that IFN-α/β, IL-12, and IL-23—but not IL-2—induced TYK2 phosphorylation in CD4+ T cells. Accordingly, TYK2 blockade selectively inhibited STAT1/2/3/4 activation downstream of these cytokines, but did not affect IL-2-induced STAT5 phosphorylation in Tregs. These lineage-selective effects were confirmed in peripheral blood mononuclear cells from autoimmune uveitis patients.Interpretation: Selective TYK2 inhibition suppresses pathogenic Th1/Th17 responses while preserving the proportion and function of Tregs, offering a precision therapeutic strategy for CNS autoimmunity by rebalancing the effector–regulatory immune axis.
- Open Access
- 9 January 2026
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (1)
Corrigendum to Neutrophil extracellular traps potentiate effector T cells via endothelial senescence in uveitis
After publication, the authors became aware that the CD3 + CD69 + flow cytometry plots for dasatinib and quercetin in Figure 7H were inadvertently transposed during figure assembly. The correct figure panels are shown below. The HTML and PDF versions have been updated online.
- 9 January 2026
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (1)
Open AccessCorrigendum to Neutrophil extracellular traps potentiate effector T cells via endothelial senescence in uveitis
After publication, the authors became aware that the CD3 + CD69 + flow cytometry plots for dasatinib and quercetin in Figure 7H were inadvertently transposed during figure assembly. The correct figure panels are shown below. The HTML and PDF versions have been updated online.
- Open Access
- 7 January 2026
- Published by Springer Nature in Cell Research
- Vol. 36 (5) , 340-358
Sensing of DNA double-strand breaks by the NHEJ system stabilizes RORγt transcriptional activity and shapes Th17 pathogenicity in autoimmunity
Robust mitochondrial ROS production induces extensive double-strand breaks (DSBs) in telomeric DNA of effector T cells, where the DNA repair machinery is rapidly hyper-evoked to sense and ligate DSBs during the respiratory burst. However, whether effector T cells can exploit the DNA repair system to simultaneously potentiate their functional activation remains largely unknown, especially in the context of autoimmunity. Here, we demonstrate that non-homologous end joining (NHEJ), a predominant mechanism of DNA repair, is highly activated in pathogenic T helper 17 (pTh17) cells and exerts a previously unrecognized effect on shaping the pathogenic nature of pTh17s to trigger autoimmunity. Mechanistically, the perception of DSBs by KU proteins facilitates auto-phosphorylation of DNA-dependent protein kinase catalytic subunit (DNA-PKcs), which stabilizes RORγt to bind to the promoters of effector-gene loci, thus initiating the pTh17 effector program to induce autoimmunity. Using mass spectrometry and transcriptome analyses, we identified IER2 as a novel NHEJ factor that potentiates DNA-PKcs kinase activity in response to IL-23R stimulation, which is necessary for shaping Th17 pathogenicity. Therefore, targeting the immuno-pattern of the NHEJ system shows potential for the treatment of autoimmune diseases.
- 7 January 2026
- Published by Springer Nature in Cell Research
- Vol. 36 (5) , 340-358
Open AccessSensing of DNA double-strand breaks by the NHEJ system stabilizes RORγt transcriptional activity and shapes Th17 pathogenicity in autoimmunity
Robust mitochondrial ROS production induces extensive double-strand breaks (DSBs) in telomeric DNA of effector T cells, where the DNA repair machinery is rapidly hyper-evoked to sense and ligate DSBs during the respiratory burst. However, whether effector T cells can exploit the DNA repair system to simultaneously potentiate their functional activation remains largely unknown, especially in the context of autoimmunity. Here, we demonstrate that non-homologous end joining (NHEJ), a predominant mechanism of DNA repair, is highly activated in pathogenic T helper 17 (pTh17) cells and exerts a previously unrecognized effect on shaping the pathogenic nature of pTh17s to trigger autoimmunity. Mechanistically, the perception of DSBs by KU proteins facilitates auto-phosphorylation of DNA-dependent protein kinase catalytic subunit (DNA-PKcs), which stabilizes RORγt to bind to the promoters of effector-gene loci, thus initiating the pTh17 effector program to induce autoimmunity. Using mass spectrometry and transcriptome analyses, we identified IER2 as a novel NHEJ factor that potentiates DNA-PKcs kinase activity in response to IL-23R stimulation, which is necessary for shaping Th17 pathogenicity. Therefore, targeting the immuno-pattern of the NHEJ system shows potential for the treatment of autoimmune diseases.
- Open Access
- 27 November 2025
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 22 (1)
Inhibition of bruton’s tyrosine kinase directly alleviates pathogenic CD4+ T cell response via PPAR-γ signaling in autoimmune uveitis
Bruton’s tyrosine kinase (BTK), a key regulator of immune responses, has been extensively studied in B cells and innate immunocytes. Small-molecule B
- 27 November 2025
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 22 (1)
Open AccessInhibition of bruton’s tyrosine kinase directly alleviates pathogenic CD4+ T cell response via PPAR-γ signaling in autoimmune uveitis
Bruton’s tyrosine kinase (BTK), a key regulator of immune responses, has been extensively studied in B cells and innate immunocytes. Small-molecule B
- 16 October 2025
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 33 (10) , 2366-2373
Ocular Characteristics Due to Bartonella Henselae Infection: A Retrospective Cohort Study in China
To characterize the ocular manifestations of Bartonella henselae infection in Chinese patients. We retrospectively investigated the ocular manifestations due to Bartonella henselae infection at Zhongshan Ophthalmic Centers in China between July 2019 and February 2025. Patients with presumptive ocular cat-scratch disease (CSD) confirmed by serum anti-B. henselae IgG titers ≥ 1:256 (via indirect immunofluorescence assay), compatible ocular findings, and possible exposure history were enrolled. Data on demographics, ocular features (visual acuity, anterior/posterior segment findings), systemic symptoms, exposure history, treatment regimens and outcomes were collected. Fourteen patients (median age 15.5 years; 71.4% male) were enrolled. Pediatric cases (n = 7) accounted for 50%, who showed aggressive bilateral involvement (6/7, 85.7%). Optic disc edema was the predominant manifestation (18/20 eyes, 90%), followed by vitreous cells (65%), anterior chamber cell (50%) and retinal vascular leakage (50%). Initial best-corrected visual acuity (BCVA) ≥0.5 was observed in 40% of eyes, rising to 85% after treatment. Systemic antibiotics were given to all the patients, and corticosteroids were added in 12 (85.7%) patients afterward. This study identifies optic disc edema as the hallmark ocular phenotype of Bartonella Henselae infection in China. Pediatric patients exhibit aggressive bilateral involvement and diffuse retinal vascular leakage. These findings suggest that ocular CSD may represent an under-recognized cause of pediatric uveitis in Chinese populations. Therapeutic outcomes in this cohort positively indicated that combined antibiotic and anti-inflammatory regimens may improve visual acuity. Further prospective multicenter studies are warranted to further validate these observations.
- 16 October 2025
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 33 (10) , 2366-2373
Ocular Characteristics Due to Bartonella Henselae Infection: A Retrospective Cohort Study in China
To characterize the ocular manifestations of Bartonella henselae infection in Chinese patients. We retrospectively investigated the ocular manifestations due to Bartonella henselae infection at Zhongshan Ophthalmic Centers in China between July 2019 and February 2025. Patients with presumptive ocular cat-scratch disease (CSD) confirmed by serum anti-B. henselae IgG titers ≥ 1:256 (via indirect immunofluorescence assay), compatible ocular findings, and possible exposure history were enrolled. Data on demographics, ocular features (visual acuity, anterior/posterior segment findings), systemic symptoms, exposure history, treatment regimens and outcomes were collected. Fourteen patients (median age 15.5 years; 71.4% male) were enrolled. Pediatric cases (n = 7) accounted for 50%, who showed aggressive bilateral involvement (6/7, 85.7%). Optic disc edema was the predominant manifestation (18/20 eyes, 90%), followed by vitreous cells (65%), anterior chamber cell (50%) and retinal vascular leakage (50%). Initial best-corrected visual acuity (BCVA) ≥0.5 was observed in 40% of eyes, rising to 85% after treatment. Systemic antibiotics were given to all the patients, and corticosteroids were added in 12 (85.7%) patients afterward. This study identifies optic disc edema as the hallmark ocular phenotype of Bartonella Henselae infection in China. Pediatric patients exhibit aggressive bilateral involvement and diffuse retinal vascular leakage. These findings suggest that ocular CSD may represent an under-recognized cause of pediatric uveitis in Chinese populations. Therapeutic outcomes in this cohort positively indicated that combined antibiotic and anti-inflammatory regimens may improve visual acuity. Further prospective multicenter studies are warranted to further validate these observations.
- Open Access
- 3 March 2025
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 66 (3) , 8
STING Deficiency Promotes Th17-Like Tfh to Aggravate the Experimental Autoimmune Uveitis
The purpose of this study was to explore the underlying mechanism that Th17-like T follicular helper cells (Tfh) orchestrated by STING signaling have a pathogenic role in experimental autoimmune uveitis (EAU). The differences of transcriptome and gene ontology (GO) pathway of Tfh between EAU and control mice were analyzed by single-cell RNA sequence (scRNA-seq) and bulk RNA sequence. Additionally, draining lymph nodes (DLNs) were extracted to verify the expression of IL-17A and IFN-γ in Tfh from EAU and control mice by flow cytometry. Then, the scRNA-seq and flow cytometry were used to explore the different proportion of Tfh between STING deficiency (Sting-/-) mice and wild type (WT) mice. In vitro, naïve CD4+ T cells were isolated from Sting-/- mice and WT mice to induce the Tfh under the induction condition. In addition, flow cytometry was used to detect the different induction ratio and the IL-17A expression between 2 groups of naïve CD4+ T cells. Compared with control mice, marked increase of Tfh was observed in EAU, accompanied by elevated levels of Th1 and Th17 cells. Moreover, Th17-related genes, such as Rorc, Il22, Il23r, Il17a, and Il17f, and the corresponding GO pathways were upregulated in Tfh from EAU. The scRNA-seq showed that a higher proportion of Tfh was observed in the DLNs from Sting-/- mice than WT mice, which was verified by flow cytometry. When STING was knocked out, the Tfh was characterized with upregulated Th17-related phenotype in vivo, and there was a higher induction ratio of Tfh whose IL-17A expression was significantly increased in vitro. Notably, the STING expression of CD4+ T cells was downregulated in the EAU. STING-deficient EAU mice displayed more severe retinal inflammation, characterized by massive infiltration of CD4+ T cells, including Th1 and Th17 subsets. Importantly, treatment with a STING agonist alleviated inflammation of EAU. Th17-like Tfh cells play a pathogenic role in the EAU. STING deficiency promotes the differentiation and phenotypic transformation of Th17-like Tfh cells, exacerbating the inflammatory response in EAU. These findings highlight the potential of targeting STING to modulate Tfh cells as a therapeutic strategy for uveitis.
- 3 March 2025
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 66 (3) , 8
Open AccessSTING Deficiency Promotes Th17-Like Tfh to Aggravate the Experimental Autoimmune Uveitis
The purpose of this study was to explore the underlying mechanism that Th17-like T follicular helper cells (Tfh) orchestrated by STING signaling have a pathogenic role in experimental autoimmune uveitis (EAU). The differences of transcriptome and gene ontology (GO) pathway of Tfh between EAU and control mice were analyzed by single-cell RNA sequence (scRNA-seq) and bulk RNA sequence. Additionally, draining lymph nodes (DLNs) were extracted to verify the expression of IL-17A and IFN-γ in Tfh from EAU and control mice by flow cytometry. Then, the scRNA-seq and flow cytometry were used to explore the different proportion of Tfh between STING deficiency (Sting-/-) mice and wild type (WT) mice. In vitro, naïve CD4+ T cells were isolated from Sting-/- mice and WT mice to induce the Tfh under the induction condition. In addition, flow cytometry was used to detect the different induction ratio and the IL-17A expression between 2 groups of naïve CD4+ T cells. Compared with control mice, marked increase of Tfh was observed in EAU, accompanied by elevated levels of Th1 and Th17 cells. Moreover, Th17-related genes, such as Rorc, Il22, Il23r, Il17a, and Il17f, and the corresponding GO pathways were upregulated in Tfh from EAU. The scRNA-seq showed that a higher proportion of Tfh was observed in the DLNs from Sting-/- mice than WT mice, which was verified by flow cytometry. When STING was knocked out, the Tfh was characterized with upregulated Th17-related phenotype in vivo, and there was a higher induction ratio of Tfh whose IL-17A expression was significantly increased in vitro. Notably, the STING expression of CD4+ T cells was downregulated in the EAU. STING-deficient EAU mice displayed more severe retinal inflammation, characterized by massive infiltration of CD4+ T cells, including Th1 and Th17 subsets. Importantly, treatment with a STING agonist alleviated inflammation of EAU. Th17-like Tfh cells play a pathogenic role in the EAU. STING deficiency promotes the differentiation and phenotypic transformation of Th17-like Tfh cells, exacerbating the inflammatory response in EAU. These findings highlight the potential of targeting STING to modulate Tfh cells as a therapeutic strategy for uveitis.